Zumutor
0 followers
About Zumutor
Zumutor is a leading immuno-oncology biotech focused on targeted NK cell therapeutics. The company leverages its proprietary INABLR human antibody platform to develop first-in-class therapeutic antibodies that target innate immunity and modulate the tumor microenvironment. Founded in 2013 and headquartered in Cambridge, MA with an R&D lab in Bangalore, India, Zumutor combines antibody engineering expertise with a platform-based approach to discover novel immunotherapies for cancer.
Recent News
No recent news for this company.
Recent Deals
No recent deals for this company.